Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy-Reference-Cited by-同舟云学术

Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy

Published:2008-12 Issue:12 Volume:139 Page:1674-1677
ISSN:0002-8177
Container-title:The Journal of the American Dental Association
language:en
Short-container-title:The Journal of the American Dental Association

Author:

Edwards Beatrice J.,Hellstein John W.,Jacobsen Peter L.,Kaltman Steven,Mariotti Angelo,Migliorati Cesar A.

Publisher

Elsevier BV

Subject

General Dentistry

Reference19 articles.

1. Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations;American Dental Association Council on Scientific Affairs;JADA,2006

2. Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly Pivotal Fracture Trial;Grbic;JADA,2008

3. Osteonecrosis of the jaw: do bisphosphonates pose a risk?;Bilezikian;N Engl J Med,2006

4. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies;Boonyapakorn;Oral Oncol,2008

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and Management of Pathological Conditions;Journal of Oral and Maxillofacial Surgery;2023-11

2. MRONJ Treatment Strategies: A Systematic Review and Two Case Reports;Applied Sciences;2023-03-29

3. Real-world study of antiresorptive-related osteonecrosis of jaw based on the US food and drug administration adverse event reporting system database;Frontiers in Pharmacology;2022-10-19

4. Bifosfonatlar ve Çenelerde Görülen Osteonekroz;Sağlık Bilimlerinde Değer;2022-05-17

5. American Association of Oral and Maxillofacial Surgeons’ Position Paper on Medication-Related Osteonecrosis of the Jaws—2022 Update;Journal of Oral and Maxillofacial Surgery;2022-05